Vetter is a family-owned, award-winning, high-performance service provider for the global pharmaceutical and biotech industry. Specializing in aseptic filling of customers’ drug products in syringes, cartridges, and vials, Vetter partners with its customers from clinical development through regulatory approval, market launch, and beyond. The company is committed to sustainability, carbon neutrality, and aligning its efforts with the United Nations' 17 Sustainable Development Goals (SDGs). With over 6,300 employees worldwide, Vetter focuses on producing customer products that improve people's lives.

Vetter

BioCina is a biologics contract development and manufacturing organization (CDMO) that provides scientific and operational services for the development and manufacture of microbial, pDNA, and mRNA-based vaccines.

BioCina

Pharma Manufacturing provides information and resources related to the pharmaceutical manufacturing sector, including industry news, articles, and events.

Pharma Manufacturing

ZETA provides engineering and related services for the pharmaceutical and biotech industries. The company offers solutions in process engineering, automation, and digitalization, along with lifecycle management and executive quality services.

Metric
Company Name	Vetter	BioCina	Pharma Manufacturing	ZETA
Symbol
MSH ID	COM:VETTER-PHARMA	COM:BIOCINA	COM:PHARMAMANUFACTURING	COM:ZETA
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Commercial & Professional Services	Commercial & Professional Services
Industry	Pharmaceutical and Biotech	Pharmaceuticals	Pharmaceuticals	Manufacturing
Country		AU	US	AT
Stage
Employee Count	5.00K	101		1.00K
Website	vetter-pharma.com	biocina.com	pharmamanufacturing.com	zeta.com
LinkedIn		biocina		zeta-gmbh
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	13.54K	24.54K
Web Traffic Growth	1.75	-0.85
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VETT

COM:VETTER-PHARMA

Vetter

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue